These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CMV pneumonia in HIV-infected ventilated infants. Goussard P; Kling S; Gie RP; Nel ED; Heyns L; Rossouw GJ; Janson JT Pediatr Pulmonol; 2010 Jul; 45(7):650-5. PubMed ID: 20575098 [TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. Li MC; Lee NY; Lee CC; Lee HC; Chang CM; Ko WC J Microbiol Immunol Infect; 2014 Feb; 47(1):42-7. PubMed ID: 23063081 [TBL] [Abstract][Full Text] [Related]
4. Gomori Methenamine Silver Stain on Bronchoalveolar Lavage Fluid Is Poorly Sensitive for Diagnosis of Azar MM; Slotkin R; Abi-Raad R; Liu Y; Grant MH; Malinis MF Arch Pathol Lab Med; 2020 Jan; ():. PubMed ID: 31904277 [TBL] [Abstract][Full Text] [Related]
5. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation. Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868 [TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516 [TBL] [Abstract][Full Text] [Related]
7. Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. Ricciardi A; Gentilotti E; Coppola L; Maffongelli G; Cerva C; Malagnino V; Mari A; Di Veroli A; Berrilli F; Apice F; Toschi N; Di Cave D; Parisi SG; Andreoni M; Sarmati L PLoS One; 2017; 12(5):e0176881. PubMed ID: 28505159 [TBL] [Abstract][Full Text] [Related]
8. Cytomegaloviral or Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509 [TBL] [Abstract][Full Text] [Related]
9. Using Routine Laboratory Markers and Immunological Indicators for Predicting Tang G; Tong S; Yuan X; Lin Q; Luo Y; Song H; Liu W; Wu S; Mao L; Liu W; Zhu Y; Sun Z; Wang F Front Immunol; 2021; 12():652383. PubMed ID: 33912176 [TBL] [Abstract][Full Text] [Related]
10. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort. Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C; Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950 [TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jiroveci pneumonia (PJP) in non-HIV immunocompromised individuals. Schoovaerts K; Dirix L; Rutten A; Van Schaeren J; Van Herendael B; Van Grieken S; Heytens L Acta Clin Belg; 2017 Dec; 72(6):413-416. PubMed ID: 28346081 [TBL] [Abstract][Full Text] [Related]
12. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation. Lu YM; Lee YT; Chang HC; Yang HS; Chang CY; Huang CM; Wei J Transplant Proc; 2017 Oct; 49(8):1893-1898. PubMed ID: 28923644 [TBL] [Abstract][Full Text] [Related]
14. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial. Newberry L; O'Hare B; Kennedy N; Selman A; Omar S; Dawson P; Stevenson K; Nishihara Y; Lissauer S; Molyneux E Paediatr Int Child Health; 2017 May; 37(2):121-128. PubMed ID: 28145162 [TBL] [Abstract][Full Text] [Related]
15. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population. Avino LJ; Naylor SM; Roecker AM Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349 [TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: Clinical manifestations and outcomes between pediatric and adult patients. Lee HY; Lu CY; Lee PI; Chen JM; Huang LM; Chang LY J Microbiol Immunol Infect; 2019 Dec; 52(6):983-990. PubMed ID: 31164278 [TBL] [Abstract][Full Text] [Related]
17. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia. Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768 [TBL] [Abstract][Full Text] [Related]
18. The Pathogenesis and Diagnosis of Apostolopoulou A; Fishman JA J Fungi (Basel); 2022 Nov; 8(11):. PubMed ID: 36354934 [No Abstract] [Full Text] [Related]
19. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS? Liebling M; Rubio E; Ie S Expert Rev Respir Med; 2015 Apr; 9(2):171-81. PubMed ID: 25771943 [TBL] [Abstract][Full Text] [Related]